Venus Remedies Ltd

Stage 3 · Topping · week 6

As of 16 Oct 2026, Venus Remedies is in Stage 3 — topping, where an uptrend loses steam, in week 6 (since 8 Sep 2026). It closed at ₹1,651, 15.2% below its 52-week high and above its 200-day average, which is rising. In Health Care, 40.0% of stocks are in Stage 2.

Venus Remedies Limited engages in the pharmaceutical business in India and internationally. More about the company

₹1,650.7
+4.99% today
₹2,209 Cr · Small cap
Market Neutral — FadingHealth Care 40.0% in Stage 2-7.4 pts / 20dPharmaceuticals 49.6%-2.5 pts

Pro read

Pro

Our read

Topping — the uptrend is tiring

Setup score

—

Momentum

Steady

Edge

—

Is VENUSREM early, or has it already run? Pro answers that for every NSE stock, after every close.

₹2,999 · 12 months₹1,999 · 6 months
Loading price chart…
vs 52W High
-15.2%
₹434.4 lo₹1,947 hi
15.2% below 52W high — weakening from peak
Stock is rolling over from its 52W high. Stage 3 distribution — new longs are high risk here.
Stage Maturity
Week 6
1w13w26w
Week 6 — distribution, avoid new longs
How long this stock has been in Stage 3 distribution. Longer tops often precede deeper Stage 4 declines.
vs 200 DMA
31.7%
200 DMA: ₹1,253.8 · rising
Stock is losing its 200 DMA. Once lost, it confirms Stage 4 risk. This is a major red flag for existing holders.
Rel Volume
0.95x
vs 50-day avg
Volume spikes on down days during Stage 3 signal distribution — institutions are exiting. A clear warning to avoid new longs.
Trend Health
↗
MA20 gently rising · +1.1% vs MA50 -0.3%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
1M
+7.5%
3M
-6.7%
6M
+58.8%
YTD
+105.0%
1Y
+262.7%
Sector
Health Care
↓ Peaking
Stage 2%
40.0%
20d Δ
-7.4pp
1M return
-3.8%
3M return
-1.0%
Sector Stage-2 % · last 20 days
Sector has 66 Stage 2 leaders. See Health Care Stage 2 →
Industry
Pharmaceuticals
↓ Peaking
Stage 2%
49.6%
20d Δ
-2.5pp
1M return
-2.3%
3M return
-0.6%
Industry Stage-2 % · last 20 days
Industry has 56 Stage 2 leaders. See Pharmaceuticals Stage 2 →
Stage Cycle Timeline2023-07-20 → 2026-10-16
S2 16w
S4 27w
S2 17w
S2 14w
S2 24w
2023-07-202026-10-16
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 7w → S3 8w → S2 16w → S3 13w → S4 3w → S1 3w → S2 9w → S3 4w → S4 27w → S1 6w → S2 17w → S3 7w → S2 14w → S3 3w → S2 24w → S3 6w current
Total tracked: 168 weeks across 16 stage runs.
Scan Membership
Pullback Hunter
Latest: 2026-07-24
Prop Scan
Latest: 2026-07-24
60 appearances in last 60 days. First seen: 2026-06-01.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-10-16S3
Wk 6 · Vol 0.95x
2026-10-15S3
Wk 6 · Vol 0.74x
2026-10-14S3
Wk 5 · Vol 0.43x
2026-10-13S3
Wk 5 · Vol 0.54x
2026-10-12S3
Wk 5 · Vol 0.41x
2026-10-09S3
Wk 5 · Vol 1.12x
2026-10-08S3
Wk 5 · Vol 0.62x
2026-10-07S3
Wk 4 · Vol 0.67x
2026-10-06S3
Wk 4 · Vol 0.55x
2026-10-05S3
Wk 4 · Vol 0.56x
2026-10-01S3
Wk 4 · Vol 3.17x
2026-09-30S3
Wk 4 · Vol 0.74x
Sector Peers — Stage 2All →
BAFNAPH
wk 19 · 0.0% from hi
8.6
KILITCH
wk 3 · -11.6% from hi
8.4
LAURUSLABS
wk 26 · -0.4% from hi
7.8
KOPRAN
wk 20 · -6.8% from hi
7.4
ZIMLAB
wk 23 · -5.2% from hi
6.9
Moving averages & range
50 DMA
₹1,655.5
200 DMA
₹1,253.8
52W High
₹1,947
52W Low
₹434.4
5D Low
₹1,572.2
Resistance levels (recent highs)
20d High
₹1,796.7
60d High
₹1,819.5
120d High
₹1,947
250d High
₹1,947
Next resistance
+8.8%
to 20d High
Ask the Market AI about VENUSREMAsk →
P/E (TTM)
21.3
Forward —
Earnings Growth (YoY)
+126.4%
Revenue +35.6%
ROE
+16.8%
Profit margin +13.1%
About this companyHealth Care· Pharmaceuticals

Venus Remedies Limited engages in the pharmaceutical business in India and internationally. It is involved in the research and development of solutions focusing on antimicrobial resistance and oncology. The company also offers analgesic, analgesic and antipyretic, antibiotic, anticoagulant, antiemetic, antiviral, cardiovascular, disinfectant and antiseptic, gastro therapy, hepatoprotective, hormones (steroid), immunostimulating agent, iron supplements, muscle relaxant, neurology, oncology, and solvent products, as well as herbal medicine. The company was incorporated in 1989 and is headquartered in Panchkula, India.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-16. Past data patterns are not indicative of future results. This page is a data analytics tool only.